FindMyKOL

Sobha Kurian, M, D

Basic profile

West Virginia University

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionMorgantown, WV · SoutheastSpecialtyHematology / OncologyFocusOncology
Active KOLFindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Sobha Kurian is an Oncology physician affiliated with West Virginia University. OpenAlex indexes 55 publications with 1,383 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
55publications

Publications indexed by OpenAlex. Counts exclude supporting files.

1,383citations

Citations across these publications.

12h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Genentech
    Program year20258 paymentsResearch
    $30,078
  • Daiichi Sankyo
    Program year20252 paymentsResearch
    $4,687
  • Daiichi Sankyo Inc.
    Program year20251 payment
    $92
All 16 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    84.1%
    Aromatase Inhibitor76.2%
    Anastrozole66%Exemestane18%Letrozole16%
    Part D≥83 patients
    Kinase inhibitor7.9%
    Ibrance100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    5.1%
    Serotonin-3 Receptor Antagonist5.1%
    Ondansetron Hcl100%
    Part D≥14 patients
  • Nervous system

    4.6%
    Phenothiazine4.6%
    Prochlorperazine Maleate100%
    Part D≥15 patients
Where care is delivered (Part B)95.8% facility · 4.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”